LEXX
Lexaria Bioscience
$0.52
−$0.04 (−6.8%)Jul 27, 2026
Key metrics
The numbers that frame LEXX today
- Market cap
- $12.91M
- P/E (TTM)
- -1.7
- EV / FCF
- -1.3
- Gross margin
- 100%
- EV / Sales
- 49.1
- ROIC
- -1,299.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.46
- 52wk High
- $1.55
Growth
Revenue and earnings trend for LEXX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LEXX
Is Lexaria Bioscience a good buy?
No. Lexaria Bioscience has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Lexaria Bioscience is selling at a very high price.
What is the market capitalization of LEXX?
Lexaria Bioscience's market capitalization is $12.91M.
What is the P/E ratio for LEXX stock?
Lexaria Bioscience's current P/E ratio is -1.7.
What is the 52-week high for LEXX stock?
The 52-week high for Lexaria Bioscience is $1.55. The current close of $0.52 is 66.4% below that high.
What is the 52-week low for LEXX stock?
The 52-week low for Lexaria Bioscience is $0.46. The current close of $0.52 is 13.3% above that low.
Does LEXX stock pay dividends?
Lexaria Bioscience does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LEXX?
Lexaria Bioscience's Debt / Equity ratio is 0.02.